Clinical Trial Update: A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating the efficacy and safety of SPM 927 in subjects with painful distal diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• SPM 927 (SPM 927)

Snippet

Sponsor: UCB Pharma | Conditions: Diabetic Neuropathy | Phase 2, Phase 3 | Status: COMPLETED